Promoters of Rossari Biotech are exploring options to sell a stake in the Mumbai-based specialty chemicals maker, amid early-stage interest from global private equity funds and a listed strategic player, according to sources familiar with the discussions. The talks are at a preliminary and exploratory stage, with no binding offers received and no final decision taken by the promoters.
The potential stake sale is being driven by the absence of a clearly defined succession roadmap, with no publicly articulated long-term plan for promoter transition so far. Founded as a specialty chemicals platform focused on high-value formulations, Rossari Biotech has built a strong presence across textiles, personal care and performance chemicals, supplying both domestic and export markets.
From a financial standpoint, the company reported revenue of ₹581.68 crore and net profit of ₹32.77 crore in the quarter ended December 2025, compared with revenue of ₹512.73 crore and net profit of ₹31.70 crore in the corresponding quarter a year earlier.
The current discussions follow an important ownership development in late 2025, when promoter Sunil Srinivasan Chari transferred 15.89% of his stake as a gift to family members and a family trust through an off-market inter-se transfer. While the move did not dilute overall promoter holding, it restructured ownership within the promoter group.
Shares of Rossari Biotech are trading 5% higher after the exclusive newsbreak at ₹570.9. The stock is down 20% over the last 12 months. For now, sources emphasise that the conversations remain non-binding, and it remains to be seen whether the interest culminates in a formal transaction.
